1. Bergamo, A, Gagliardi, R, Scarcia, V, Furlani, A, Alessio, E, Mestroni, G & Sava, G (1999). In vitro cell cycle arrest in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin. J Pharmacol Exp Ther, 289: 559–564.
2. Bussolino, F, Di Renzo, MF, Ziche, M, Bocchietto, E, Olivero, M, Naldini, L, Gaudino, G, Tamagnone, L, Coffer, A & Comoglio, PM (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol, 119: 629–641.
3. Carmeliet, P & Jain, RK (2000). Angiogenesis in cancer and other disease. Nature, 407: 249–257.
4. Clarke, MJ & Stubbs, M (1996). Interactions of metallopharmaceuticals with DNA. In Metal ions in biological systems,, Sigel A, Sigel H (eds) pp 727–780, New York: Marcel Dekker
5. Cocchietto, M & Sava, G (2000). Blood concentration and toxicity of the antimetastasis agent NAMI-A following repeated intravenous treatment in mice. Pharmacol Toxicol, 87: 193–197.